Paper ยท 35704792
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.
Dbouk M and 22 others. J Clin Oncol, 2022. Cited by 212 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. Papers, record 35704792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35704792
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Pancreatic Ductal | Major topic |
| Pancreatic Neoplasms | Major topic |
| Early Detection of Cancer | |
| Humans | |
| Pancreas |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA176828 | NCI NIH HHS | United States | R01CA176828 | PubMed and NIH | NIH RePORTER |
| P50 CA062924 | NCI NIH HHS | United States | P50CA062924 | PubMed and NIH | NIH RePORTER |
| UL1 TR001863 | NCATS NIH HHS | United States | UL1TR001863 | PubMed and NIH | NIH RePORTER |
| P30 DK132710 | NIDDK NIH HHS | United States | P30DK132710 | PubMed and NIH | NIH RePORTER |
| U01 CA210170 | NCI NIH HHS | United States | U01CA210170 | PubMed and NIH | NIH RePORTER |
| P30 CA013696 | NCI NIH HHS | United States | P30CA013696 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06330441 | Pancreatic Cancer Screening in a Population at High Risk | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 35,862,875 | Building on More Than 20 Years of Progress in Pancreatic Cancer Surveillance for High-Risk Individuals. | https://conductscience.org/library/papers/35862875 | PubMed |
| Comment in | 36,315,928 | Winning the Battle But Losing the War: Single-Cancer Screening Trials. | https://conductscience.org/library/papers/36315928 | PubMed |
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,351,646 | Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes. | Cancer | 2021 | https://conductscience.org/library/papers/34351646 | PubMed |
| 2 | 32,416,142 | AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. | Gastroenterology | 2020 | https://conductscience.org/library/papers/32416142 | PubMed |
| 3 | 18,497,537 | Survival in familial pancreatic cancer. | Pancreatology | 2008 | https://conductscience.org/library/papers/18497537 | PubMed |
| 4 | 15,059,921 | Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. | Cancer Res | 2004 | https://conductscience.org/library/papers/15059921 | PubMed |
| 5 | 16,931,950 | Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. | Am J Surg Pathol | 2006 | https://conductscience.org/library/papers/16931950 | PubMed |
| 6 | 30,883,245 | Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/30883245 | PubMed |
| 7 | 30,946,242 | Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis. | Pancreas | 2019 | https://conductscience.org/library/papers/30946242 | PubMed |
| 8 | 31,197,699 | Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer. | J Gastrointest Surg | 2020 | https://conductscience.org/library/papers/31197699 | PubMed |
| 9 | 21,129,377 | Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. | Gastroenterology | 2011 | https://conductscience.org/library/papers/21129377 | PubMed |
| 10 | 33,406,487 | Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2021 | https://conductscience.org/library/papers/33406487 | PubMed |
1 to 10 of 43
See all 43 referencesCited by141
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 212 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,881,815 | The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma from High-Risk Controls: A Retrospective Secondary Analysis. | J Clin Med | 2026 | https://conductscience.org/library/papers/42881815 | PubMed |
| 42,877,528 | Strategy for early diagnosis of pancreatic cancer. | Front Gastroenterol (Lausanne) | 2026 | https://conductscience.org/library/papers/42877528 | PubMed |
| 42,806,196 | Invariant Texture Features to Gray Level Discretization. | J Imaging Inform Med | 2026 | https://conductscience.org/library/papers/42806196 | PubMed |
| 42,795,025 | Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichment: An AI-Assisted Volumetric Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42795025 | PubMed |
| 42,776,526 | Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42776526 | PubMed |
| 42,749,887 | Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. | Nat Med | 2026 | https://conductscience.org/library/papers/42749887 | PubMed |
| 42,741,119 | Efficacy of UFT combined with radiotherapy in advanced pancreatic cancer: a systematic review and meta-analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42741119 | PubMed |
| 42,640,275 | Pancreatic cysts on MRI: prevalence and factors associated with reporting. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/42640275 | PubMed |
| 42,557,274 | Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42557274 | PubMed |
| 42,541,517 | Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain. | Fam Cancer | 2026 | https://conductscience.org/library/papers/42541517 | PubMed |
1 to 10 of 141
See all 141 cited byGenes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| CAPS | 828 | PubTator's text mining | https://conductscience.org/library/genes/828 | NCBI Gene |
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| GNAS | 2,778 | PubTator's text mining | https://conductscience.org/library/genes/2778 | NCBI Gene |
| PALB2 | 79,728 | PubTator's text mining | https://conductscience.org/library/genes/79728 | NCBI Gene |
| SCT | 6,343 | PubTator's text mining | https://conductscience.org/library/genes/6343 | NCBI Gene |
| TERT | 7,015 | PubTator's text mining | https://conductscience.org/library/genes/7015 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35704792
GET https://conductscience.org/api/papers/v1/35704792/authors?page=2